Tilray | TRLY - Stock


Tilray reported $282.79M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Akebia Therapeutics USD 13M 2.61M Mar/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Avita Medical AUD 6.93M 614K Dec/2025
Canopy Growth CAD 110.51M 4.96M Mar/2026
Cronos Group USD 46.75M 1.42M Dec/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Moderna USD 146M 7M Mar/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Organon & Co USD 1.37B 33M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 3.93B 72.2M Mar/2026
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024